PhaseBio Pharmaceuticals, Inc. Announces the Appointment of Kathryn J. Gregory Vice President of Business Development
4/27/2011 8:31:32 AM
MALVERN, Pa.--(BUSINESS WIRE)--PhaseBio Pharmaceuticals, Inc., a privately held, clinical-stage biotechnology company developing novel drugs to treat diabetes, metabolic disease and cardiovascular disease, announced today that Kathryn J. Gregory has been appointed Vice President of Business Development. Ms. Gregory has more than 20 years of experience in international business development with a proven track record of negotiating deals and partnerships.
comments powered by